MedPath

Phase Angle as a Marker of Muscle Damage, Muscle Fatigue and Inflammation, After Eccentric Exercise

Not Applicable
Recruiting
Conditions
Phase Angle
Registration Number
NCT05583500
Lead Sponsor
Universidad Francisco de Vitoria
Brief Summary

The purpose of this study will be to assess the effectiveness of bioimpedance device (BIA) as a safe, rapid, and non-invasive method of analyzing muscle damage induced by high intensity induced eccentric exercise as an alternative measurement tool against traditional assessment methods.

A sample of 28 sedentary subjects will be recruited, all participants will perform an eccentric exercise protocol.

Measurements will be done before performing the exercise protocol, immediately after finishing the protocol, 3h after the end of the exercise protocol, 24h after the end of the exercise protocol and 48h after the end of the exercise protocol.

The variables analyzed in all subjects will be phase angle, creatinkinase, jumping strength, VAS scale, white blood count cell, quadriceps muscle thickness, Borg scale and anxiety and depression questionnaires.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
28
Inclusion Criteria
  • Healthy subjets
  • Sedentary subjects
Exclusion Criteria
  • Trained subjects
  • Subjects with musculoskeletal pathology
  • Previous Surgeries in the last 6 months
  • Subjects under pharmacological treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Phase anglechange from baseline to 72 hours

The phase angle, which is measured via bioelectrical impedance analysis (BIA), InBody 770 ,is a clinically important bioimpedance parameter used for nutritional assessment and evaluating the risk of various diseases. The phase angle was calculated automatically by the BIA device from these two components according to the following formula: phase angle (°) = (reactance/resistance) × (180°/π).

Secondary Outcome Measures
NameTimeMethod
Creatinkinase (CK concentration)change from baseline to 72 hours

CK concentration will be measure in mg/dl with a portal analyzer (SpotchemTM EZ SP-4430), using test strips.

cellular inflammatory markerschange from baseline to 72 hours

Cellular inflammatory markers will be measured with hematology analyzer (Sysmex KX-21N Automed) in 10\^9/L and % White blood count, lymphocytes, neutrophils, monocytes, eosinophils, basophils will be analyzed

Pain: VASchange from baseline to 72 hours

Visual Analogic Scale. Pain will be measured with a visual analog scale from 0 to 10. 0 points is no pain.

Quadriceps thicknesschange from baseline to 72 hours

Quadriceps muscle thickness will be measures in mm. by an ultrasound device

Leg powerchange from baseline to 72 hours

Leg power will be assessed using vertical jump test, with Chronojump platform (CHRONOJUMP Boscosystem)

Trial Locations

Locations (1)

Universidad Francisco de Vitoria

🇪🇸

Pozuelo De Alarcón, Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath